1. Home
  2. OSS vs BIVI Comparison

OSS vs BIVI Comparison

Compare OSS & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OSS

One Stop Systems Inc.

HOLD

Current Price

$7.10

Market Cap

150.4M

Sector

Technology

ML Signal

HOLD

Logo BioVie Inc.

BIVI

BioVie Inc.

HOLD

Current Price

$1.22

Market Cap

10.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSS
BIVI
Founded
1998
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.4M
10.8M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
OSS
BIVI
Price
$7.10
$1.22
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
599.1K
74.6K
Earning Date
11-05-2025
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$60,264,017.00
N/A
Revenue This Year
$18.00
N/A
Revenue Next Year
$9.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.33
N/A
52 Week Low
$1.85
$1.16
52 Week High
$7.92
$25.76

Technical Indicators

Market Signals
Indicator
OSS
BIVI
Relative Strength Index (RSI) 56.73 27.36
Support Level $6.50 $1.40
Resistance Level $7.77 $1.46
Average True Range (ATR) 0.50 0.09
MACD -0.04 -0.02
Stochastic Oscillator 42.25 9.47

Price Performance

Historical Comparison
OSS
BIVI

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: